Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of muscle contraction.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of muscle contraction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.989 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.988 | ||
| HDAC6 | histone deacetylase 6 | 0.976 | ||
| PRKCB | protein kinase C, beta | 0.973 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.901 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.900 | ||
| VPS29 | vacuolar protein sorting 29 homolog (S. cerevisiae) | 0.848 | ||
| PRKCA | protein kinase C, alpha | 0.794 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.566 | ||
| TNNC1 | troponin C type 1 (slow) | 0.561 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.472 | ||
| TRIM9 | tripartite motif containing 9 | 0.411 | ||
| PRKCD | protein kinase C, delta | 0.295 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.274 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.218 | ||
| TNNI1 | troponin I type 1 (skeletal, slow) | 0.190 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.166 | ||
| ARRDC3 | arrestin domain containing 3 | 0.164 | ||
| HTT | huntingtin | 0.142 | ||
| TNNI2 | troponin I type 2 (skeletal, fast) | 0.131 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.113 | ||
| LDB3 | LIM domain binding 3 | 0.092 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.068 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.068 | Mouse | |
| IL8 | interleukin 8 | 0.068 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.063 | ||
| MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle | 0.060 | ||
| TUBB2B | tubulin, beta 2B | 0.050 | ||
| RIN3 | Ras and Rab interactor 3 | 0.050 | ||
| ADORA2A | adenosine A2a receptor | 0.049 | ||
| MYH7 | myosin, heavy chain 7, cardiac muscle, beta | 0.049 | ||
| CKM | creatine kinase, muscle | 0.048 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.047 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.047 | Mouse | |
| REEP5 | receptor accessory protein 5 | 0.046 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.046 | ||
| TNNC2 | troponin C type 2 (fast) | 0.045 | ||
| MRVI1 | murine retrovirus integration site 1 homolog | 0.043 | Mouse | |
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.043 | ||
| OSBP2 | oxysterol binding protein 2 | 0.042 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.042 | ||
| ACTA1 | actin, alpha 1, skeletal muscle | 0.039 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.035 | ||
| FRZB | frizzled-related protein | 0.035 | ||
| SGCA | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | 0.034 | ||
| ACTB | actin, beta | 0.034 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.030 | ||
| LRFN1 | leucine rich repeat and fibronectin type III domain containing 1 | 0.030 | ||
| CFL2 | cofilin 2 (muscle) | 0.029 | ||
| SIRT6 | sirtuin 6 | 0.029 | ||
| NACAD | NAC alpha domain containing | 0.028 | ||
| PYGM | phosphorylase, glycogen, muscle | 0.028 | ||
| PDE6G | phosphodiesterase 6G, cGMP-specific, rod, gamma | 0.028 | ||
| TNNI3 | troponin I type 3 (cardiac) | 0.027 | ||
| ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | 0.027 | ||
| TRIM63 | tripartite motif containing 63 | 0.027 | ||
| COX6A2 | cytochrome c oxidase subunit VIa polypeptide 2 | 0.026 | ||
| ATP13A2 | ATPase type 13A2 | 0.025 | ||
| TMEM98 | transmembrane protein 98 | 0.025 | ||
| TBC1D10A | TBC1 domain family, member 10A | 0.025 | ||
| PKN1 | protein kinase N1 | 0.025 | ||
| TNNT2 | troponin T type 2 (cardiac) | 0.025 | Human | |
| ZKSCAN5 | zinc finger with KRAB and SCAN domains 5 | 0.025 | ||
| BIN1 | bridging integrator 1 | 0.024 | ||
| PASK | PAS domain containing serine/threonine kinase | 0.023 | ||
| MME | membrane metallo-endopeptidase | 0.022 | ||
| ACTN3 | actinin, alpha 3 | 0.022 | ||
| MYH6 | myosin, heavy chain 6, cardiac muscle, alpha | 0.022 | ||
| C7orf36 | chromosome 7 open reading frame 36 | 0.022 | ||
| TNNT3 | troponin T type 3 (skeletal, fast) | 0.022 | Human | |
| CHD3 | chromodomain helicase DNA binding protein 3 | 0.021 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.021 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.020 | ||
| FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.020 | ||
| MYH2 | myosin, heavy chain 2, skeletal muscle, adult | 0.020 | ||
| EZR | ezrin | 0.020 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.020 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.020 | ||
| MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.019 | ||
| RAMP1 | receptor (G protein-coupled) activity modifying protein 1 | 0.019 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.019 | ||
| EGR3 | early growth response 3 | 0.019 | ||
| MYBPH | myosin binding protein H | 0.019 | ||
| ZNF768 | zinc finger protein 768 | 0.019 | ||
| MYBPC2 | myosin binding protein C, fast type | 0.019 | ||
| ARRB2 | arrestin, beta 2 | 0.018 | ||
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.018 | ||
| MYL3 | myosin, light chain 3, alkali; ventricular, skeletal, slow | 0.018 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.018 | ||
| CDCP1 | CUB domain containing protein 1 | 0.017 | ||
| TPM1 | tropomyosin 1 (alpha) | 0.017 | ||
| NINL | ninein-like | 0.017 | ||
| OPRD1 | opioid receptor, delta 1 | 0.017 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.017 | ||
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | 0.016 | ||
| ACTG1 | actin, gamma 1 | 0.016 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.016 | ||
| RABAC1 | Rab acceptor 1 (prenylated) | 0.016 | ||
| MYH1 | myosin, heavy chain 1, skeletal muscle, adult | 0.016 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.016 | ||
| CAV2 | caveolin 2 | 0.016 | ||
| NBEAL2 | neurobeachin-like 2 | 0.016 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.016 | ||
| PGAM2 | phosphoglycerate mutase 2 (muscle) | 0.015 | ||
| CTSB | cathepsin B | 0.015 | ||
| ANKRD2 | ankyrin repeat domain 2 (stretch responsive muscle) | 0.015 | ||
| SIRT2 | sirtuin 2 | 0.015 | ||
| ACTN2 | actinin, alpha 2 | 0.015 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.015 | ||
| ZNF250 | zinc finger protein 250 | 0.015 | ||
| RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 0.014 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.014 | ||
| AKAP8L | A kinase (PRKA) anchor protein 8-like | 0.014 | ||
| PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | 0.014 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.014 | ||
| PTP4A3 | protein tyrosine phosphatase type IVA, member 3 | 0.014 | ||
| MIIP | migration and invasion inhibitory protein | 0.014 | ||
| CALCRL | calcitonin receptor-like | 0.014 | Rat | |
| PLEKHF1 | pleckstrin homology domain containing, family F (with FYVE domain) member 1 | 0.014 | ||
| MYOG | myogenin (myogenic factor 4) | 0.014 | ||
| SDPR | serum deprivation response | 0.013 | ||
| LMOD1 | leiomodin 1 (smooth muscle) | 0.013 | ||
| TBXA2R | thromboxane A2 receptor | 0.013 | ||
| HDAC11 | histone deacetylase 11 | 0.013 | ||
| ITPR3 | inositol 1,4,5-trisphosphate receptor, type 3 | 0.013 | ||
| SYNPO2L | synaptopodin 2-like | 0.013 | ||
| HECW2 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | 0.013 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.013 | ||
| MAN2A2 | mannosidase, alpha, class 2A, member 2 | 0.013 | ||
| TAZ | tafazzin | 0.013 | ||
| MYH4 | myosin, heavy chain 4, skeletal muscle | 0.013 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.013 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.013 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.013 | ||
| FCHO1 | FCH domain only 1 | 0.013 | ||
| ACTC1 | actin, alpha, cardiac muscle 1 | 0.013 | ||
| GNAS | GNAS complex locus | 0.013 | ||
| GP1BB | glycoprotein Ib (platelet), beta polypeptide | 0.013 | ||
| TCAP | titin-cap (telethonin) | 0.013 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.012 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.012 | ||
| ZRANB1 | zinc finger, RAN-binding domain containing 1 | 0.012 | ||
| DSCAML1 | Down syndrome cell adhesion molecule like 1 | 0.012 | ||
| MYL2 | myosin, light chain 2, regulatory, cardiac, slow | 0.012 | ||
| ZFAND5 | zinc finger, AN1-type domain 5 | 0.012 | ||
| CBX8 | chromobox homolog 8 | 0.012 | ||
| HLF | hepatic leukemia factor | 0.012 | ||
| NPPB | natriuretic peptide B | 0.012 | ||
| MPP3 | membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) | 0.012 | ||
| PRSS23 | protease, serine, 23 | 0.012 | ||
| P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 0.012 | ||
| RYR1 | ryanodine receptor 1 (skeletal) | 0.012 | ||
| IMPDH1 | IMP (inosine 5'-monophosphate) dehydrogenase 1 | 0.012 | ||
| TPM2 | tropomyosin 2 (beta) | 0.012 | ||
| HRC | histidine rich calcium binding protein | 0.012 | ||
| TTN | titin | 0.012 | ||
| P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | 0.012 | ||
| MYL1 | myosin, light chain 1, alkali; skeletal, fast | 0.012 | ||
| FBXO25 | F-box protein 25 | 0.012 | ||
| CA3 | carbonic anhydrase III, muscle specific | 0.011 | ||
| SLN | sarcolipin | 0.011 | ||
| CAV3 | caveolin 3 | 0.011 | ||
| KCNMB1 | potassium large conductance calcium-activated channel, subfamily M, beta member 1 | 0.011 | ||
| KCNIP3 | Kv channel interacting protein 3, calsenilin | 0.011 | ||
| RIMS4 | regulating synaptic membrane exocytosis 4 | 0.011 | ||
| MYH3 | myosin, heavy chain 3, skeletal muscle, embryonic | 0.011 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.011 | ||
| CLN6 | ceroid-lipofuscinosis, neuronal 6, late infantile, variant | 0.011 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.011 | ||
| IL1B | interleukin 1, beta | 0.011 | ||
| SRL | sarcalumenin | 0.011 | ||
| SMPX | small muscle protein, X-linked | 0.011 | ||
| SRPK3 | SRSF protein kinase 3 | 0.011 | ||
| PLN | phospholamban | 0.011 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.011 | ||
| RGS14 | regulator of G-protein signaling 14 | 0.010 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.010 | ||
| ATF3 | activating transcription factor 3 | 0.010 | ||
| FHL1 | four and a half LIM domains 1 | 0.010 | ||
| ZNF205 | zinc finger protein 205 | 0.010 | ||
| SIX1 | SIX homeobox 1 | 0.010 | ||
| ROM1 | retinal outer segment membrane protein 1 | 0.010 | ||
| ENO3 | enolase 3 (beta, muscle) | 0.010 | ||
| GPRC5B | G protein-coupled receptor, family C, group 5, member B | 0.010 | ||
| C9orf167 | chromosome 9 open reading frame 167 | 0.010 | ||
| TBX1 | T-box 1 | 0.010 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.010 | ||
| SH3BP1 | SH3-domain binding protein 1 | 0.010 | ||
| UCP3 | uncoupling protein 3 (mitochondrial, proton carrier) | 0.010 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.010 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.010 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.010 | ||
| CSNK1E | casein kinase 1, epsilon | 0.010 |